KANSAS CITY, Mo. and PALO ALTO, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Cerner Corp. (CERN) today announced a multi-year agreement with Livongo Health™ to connect diabetes screening data collected from "smart" consumer devices with Cerner health care clients. For people with diabetes, this can mean more effective self-management and a better use of time with their clinician. For care teams, this provides near real-time access to patient information, enabling quick interventions when a patient might be headed toward trouble.
The relationship is the latest advancement in Cerner's broad population health strategy to foster greater consumer and clinical device connectivity inside and out of care facilities.
Livongo is focused on empowering people with chronic conditions to live better. With approximately 9 percent of the U.S. population affected by diabetes, Livongo's first offering – Livongo for Diabetes – improves the care model for one of the country's most prevalent health conditions. In addition, the Centers for Disease Control (CDC) estimates that diabetes costs in the United States add up to $245 billion a year in medical care and lost work and wages. The Cerner-Livongo relationship aims to decrease that cost by helping patients and providers proactively manage this chronic condition, thus avoiding high-cost care.1
While the traditional diabetes care model relies heavily on in-clinic monitoring and direct physician interaction, the Livongo device remotely transmits the information to a smart cloud for analysis. Actionable information is then quickly returned to the individual and members of their care team.
Patients use Livongo's cellular-enabled blood glucose meter to measure their blood glucose levels, which are then automatically sent to the individuals they've designated, including physicians, family members, care coordinators and population health managers or other members of their care team. The device also passively collects information on activity and records behavioral information. Once the information is shared, that person's care team can provide support if values are outside of their normal range.
"We are excited to be working with Cerner," said Glen Tullman, Chief Executive Officer of Livongo Health. "This relationship enables us to rapidly deploy the latest innovative technology globally, making a difference in the lives of people with diabetes while at the same time helping to address the cost of treatment that all too often limits care. The combination of Cerner's architecture with Livongo's real-time diabetes ecosystem finally offers the ability for healthcare organizations to cost-effectively and efficiently extend care for chronic conditions beyond the four walls of the hospital."
Livongo is one of many organizations to use Cerner's CareAware approach to device connectivity outside the clinical setting, a key component of Cerner's vision to centralize the focus of care around the patient rather than the provider.
"This is the right program at the right time to empower our clients and their patients with the real-time information they need to help effectively manage and improve their health," said Zane Burke, President of Cerner. "It fits perfectly with our vision for population health, which is to provide clarity to millions of data points in an actionable and timely way to improve health and care outcomes across the population."
1 Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services; 2014.
About Livongo Health
Livongo Health™ is reinventing the way people manage chronic conditions, beginning with diabetes. Livongo is focused on improving the experience for people with diabetes, the people who care for them (family, friends, physicians), and the people who pay for their care. By offering the right information, tools and support, at the right time, we empower people with diabetes to live better and improve their health while reducing the cost of care. For more information visit: www.livongo.com.
About Cerner
Cerner's health information technologies connect people, information and systems at more than 14,000 facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients' clinical, financial and operational needs. Cerner's mission is to contribute to the improvement of health care delivery and the health of communities. Nasdaq: CERN. For more information about Cerner, visit cerner.com, read our blog at cerner.com/blog, connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner.
Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All other non-Cerner marks are the property of their respective owners.
All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. Statements relating to the expected benefits of the proposed transaction and Cerner's post-transaction plans, objectives, expectations and intentions are examples of such forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner's management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. In many instances, the words "plans", "estimates", "intends", "believe", "position", "expects", "will" or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: risks inherent with business acquisitions and integrations such as difficulties and operational and financial risks associated with integrating Cerner and the acquired business; the occurrence of any event, change or other circumstances that could give rise to the termination of the transaction agreements; the risk that the necessary regulatory approvals may not be obtained in a timely manner or may be obtained subject to conditions that are not anticipated; the risk of uncertainty as to timing of the consummation of the acquisition; risks that any of the closing conditions to the proposed transaction may not be satisfied or may not be satisfied in a timely manner; risks related to disruption of management time from ongoing business operations due to the proposed transaction; failure to realize the synergies and other benefits expected from the proposed transaction; risk that the assets and business acquired may not continue to be commercially successful; the effect of the announcement of the proposed transaction and the transaction itself on the ability of Cerner to retain customers and retain and hire key personnel and maintain relationships with key suppliers; unexpected costs, charges or expenses resulting from the transaction; and litigation or claims relating to the transaction or the acquired assets and business. Additional discussion of other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Cerner undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.